comparemela.com
  1. Home
  2. Live Updates
  3. Sequana Medical NV: Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis : comparemela.com

Sequana Medical NV: Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

Sequana Medical NV: Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Canada ,Belgium ,America ,American ,Timur Resch ,Cian Crosbie ,Stefan Klotter ,Company Or Sequanamedical ,Health Solutions ,Drug Administration ,Euronext Brussels ,Premarket Approval ,Global Vice President ,Sequana Medical ,Chief Executive Officer ,North American ,Pivotal Cohort ,Major Adverse Events ,North American Consortium ,End Stage Liver ,North America ,Glomerular Filtration Rate ,End Stage Liver Disease ,Lassen Sie ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.